1Noble W, Planel E, Zehr C, et al. Inhibition of glycogen synthase kinase -3 by lithium correlates with reduced tauopathy and degeneration in vivo [J]. PNAS, 2005, 102(19) :6990-6995.
2Shelton SB, Johnson GV. Cyclin-dependent kinase-5 in neurodegeneration[J]. J Neurochem, 2004, 88 ( 6 ) : 1313-1326.
3Li L, Sengupta A, Haque N, et al. Memantine inhibits and reverses the Alzheimer type abnormal hyperphosphorylation of tau and associated neurodegeneration [J]. FEBS Lett, 2004,566 (1-3): 261-269.
4Tariot PN, Farlow MR, Grossberg GT, et al. Memantine treatment in patients with moderate to severe Alzheimer' s disease already receiving donepezil[J]. JAMA,2004,291(3) :317-324.
5Tanimukai H,Grundke-Iqbal I, Iqbal K. Up-regulation of inhibitors of protein phosphatase-2A in Alzheimer's disease[J]. Am J Pathol, 2005,166(6) : 1761-1771.
6Le Corre S,Klafki HW,Plesnila N,et al. An inhibitor of tau hyperphosphorylation prevents severe motor impairments in tau transgenie mice[J]. Proc Natl Acad Sci USA, 2006,103 (25) : 9673-9678.
7Klafki HW, Staufenbiel M, Kornhuber J, et al. Therapeutic approaches to Alzheimer' s disease[J]. Brain, 2006,129(11) :2840-2855.
8Dickey CA, Kamal A, Lundgren K, et al. The high-affinity HSPg0-CHIP complex recognizes and selectively degrades phosphorylated tau client proteins[J]. J Clin Invest,2007,117(3):648-658.
9Pickhardt M,Gazova Z,von Bergen M,et al. Anthraquinones inhibit tau aggregation and dissolve Alzheimeres paired elieal filaments in vitro and in cells[J]. J Biol Chem,2005, 280(5) :3628-3635.
10Galas MC, Dourlen P, Begard S, et al. The peptidylprolyl cis/trans-isomerase pinl modulates stressinduced dephosphorylation of tau in neurons[J]. J Biol Chem,2006,281(28) : 19296-19304.
